Kan Q. Wu

No.34, Yanguan Road
Hangzhou, 310002, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Synergistic efficacy of radiotherapy and immunotherapy enhances clinical outcomes in patients with advanced non-small cell lung cancer.

Synergistic efficacy of radiotherapy and immunotherapy enhances clinical outcomes in patients with advanced non-small cell lung cancer.

Journal: Discover oncology

Published: December 15, 2025

Patient-derived malignant effusion organoids guide tailored therapy and dissect third-generation EGFR-tyrosine kinase inhibitor resistance mechanisms in lung cancer.

Patient-derived malignant effusion organoids guide tailored therapy and dissect third-generation EGFR-tyrosine kinase inhibitor resistance mechanisms in lung cancer.

Journal: Cancer letters

Published: September 07, 2025

Corrigendum to "SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer" [Cancer Lett. 524 (2022) 268-283].

Corrigendum to "SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer" [Cancer Lett. 524 (2022) 268-283].

Journal: Cancer letters

Published: November 24, 2024

Comprehensive analysis to identify IL7R as a immunotherapy biomarker from pan-cancer analysis to in vitro validation.

Comprehensive analysis to identify IL7R as a immunotherapy biomarker from pan-cancer analysis to in vitro validation.

Journal: Discover oncology

Published: June 18, 2024

Correlation between serum IgM antibody and viral load with clinical symptoms in neonates infected with cytomegalovirus

Correlation between serum IgM antibody and viral load with clinical symptoms in neonates infected with cytomegalovirus

Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]

Published: November 13, 2022

Positive Correlation of Peripheral CD8+ T Lymphocytes with Immune-Related Adverse Events and Combinational Prognostic Value in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.

Positive Correlation of Peripheral CD8+ T Lymphocytes with Immune-Related Adverse Events and Combinational Prognostic Value in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.

Journal: Cancers

Published: June 18, 2022

SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer.

SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer.

Journal: Cancer letters

Published: June 17, 2021

Suberoylanilide hydroxamic acid enhances the radiosensitivity of lung cancer cells through acetylated wild-type and mutant p53-dependent modulation of mitochondrial apoptosis.

Suberoylanilide hydroxamic acid enhances the radiosensitivity of lung cancer cells through acetylated wild-type and mutant p53-dependent modulation of mitochondrial apoptosis.

Journal: The Journal of international medical research

Published: February 09, 2021

Pemetrexed-Platinum With or Without Bevacizumab for Chinese Chemo-Naive Advanced Lung Adenocarcinoma Patients: A Real-World Study.

Pemetrexed-Platinum With or Without Bevacizumab for Chinese Chemo-Naive Advanced Lung Adenocarcinoma Patients: A Real-World Study.

Journal: Frontiers in pharmacology

Published: January 04, 2021

Capilliposide C from Lysimachia capillipes Restores Radiosensitivity in Ionizing Radiation-Resistant Lung Cancer Cells Through Regulation of ERRFI1/EGFR/STAT3 Signaling Pathway.

Capilliposide C from Lysimachia capillipes Restores Radiosensitivity in Ionizing Radiation-Resistant Lung Cancer Cells Through Regulation of ERRFI1/EGFR/STAT3 Signaling Pathway.

Journal: Frontiers in oncology

Published: December 20, 2020

Erratum to "Timing in combination with radiotherapy and patterns of disease progression in non-small cell lung cancer treated with EGFR-TKI" [Lung Cancer, 140 (February) (2020) 65-70].

Erratum to "Timing in combination with radiotherapy and patterns of disease progression in non-small cell lung cancer treated with EGFR-TKI" [Lung Cancer, 140 (February) (2020) 65-70].

Journal: Lung cancer (Amsterdam, Netherlands)

Published: March 03, 2020

A phase II study of concurrent nab-paclitaxel/carboplatin combined with thoracic radiotherapy in locally advanced squamous cell lung cancer.

A phase II study of concurrent nab-paclitaxel/carboplatin combined with thoracic radiotherapy in locally advanced squamous cell lung cancer.

Journal: Journal of thoracic disease

Published: January 07, 2020

Showing 1-12 of 27

Last Updated: 09/26/2026